Dr. Godson Ifeanyi Oguchi, MD

Dr. Oguchi practices at AdventHealth Fish Memorial in Orange City, Florida, part of AdventHealth.

Dr. Oguchi's NPI, 1245200906, was assigned on January 25, 2006. Dr. Oguchi graduated from University of Nigeria Faculty of Medicine in 1988. Dr. Oguchi holds Florida license ME89341.

Dr. Oguchi's primary practice is AdventHealth Fish Memorial, at 1055 Saxon Blvd, Orange City, FL 32763 in Volusia County. The practice phone is (386) 917-5000.

Dr. Oguchi's primary practice is AdventHealth Fish Memorial in Orange City, Florida, part of AdventHealth. Dr. Oguchi is also affiliated with AdventHealth Orlando. Dmand AI also links Dr. Oguchi to 2 more hospitals, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oguchi practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Oguchi's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Oguchi is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Oguchi's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists acute sinusitis, acute skin infection, bronchitis, chronic diabetes, chronic embolism thrombosis, chronic skin ulcer, cold sores or genital herpes and contact dermatitis among the conditions Dr. Oguchi treats.

CMS data shows 22,917 Medicare services from Dr. Oguchi across 14 procedure codes in 2024, for 558 Medicare patients. Medicare paid $512,379 for them.

CMS counts 558 Medicare patients who saw Dr. Oguchi in 2024. The largest group is 75 to 84, with 201 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oguchi's median patient age at 69, with 49% women.

In 2024, Dr. Oguchi wrote 3,884 Medicare Part D claims for 508 patients. 52% of them were for generic drugs. CMS names the drug for 3,589 of them, across 63 drugs with 11 or more claims each, at $6,630,770 in total drug cost. In 2023, CMS named 3,408 claims across 63 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Oguchi for performance year 2024, reported individually. Dr. Oguchi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 441 procedures of removal of tissue by Dr. Oguchi, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Oguchi, published from 2015 to 2021. Dr. Oguchi's most frequent co-authors are Michael Thomas Bennett, MD, Reem H. Ghalib, MD and Adit A. Ginde, MD.

Dmand AI links Dr. Oguchi to 8 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include COVID-19, Crohn Disease and Inflammatory Bowel Diseases. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Oguchi that name 2 trials.

CMS Open Payments shows 1,035 general payments to Dr. Oguchi from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. ViiV Healthcare Company paid the most, $21,177. It also lists 14 research payments totaling $43,949 from 2016 to 2022, naming 2 clinical trials.

Dr. Oguchi graduated from University of Nigeria Faculty of Medicine in 1988.

Dr. Oguchi is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.